{"database": "lobbying", "table": "lobbying_activities", "rows": [[1333031, "029ad4a8-6527-4f9c-8a12-7abc76fa4ac9", "Q4", "PARRY, ROMANI, DECONCINI & SYMMS", 30792, "AMGEN USA INC.", 2012, "fourth_quarter", "MMM", "Medicare Part D reimbursement issues dealing with patient payments in the \"doughnut hole.\"  No legislation introduced.\n\nMonitor PDUFA (Prescription Drug User Fee Act) reauthorization under S. 3187, Food and Drug Administration Safety and Innovation Act.", "SENATE", 45000, null, 0, 0, "2013-01-11T14:32:56.727000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1333031"], "units": {}, "query_ms": 0.4231880884617567, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}